Achieve Life Sciences (ACHV) Change in Account Payables (2012 - 2026)

Achieve Life Sciences (ACHV) has 15 years of Change in Account Payables data on file, last reported at -$53000.0 in Q1 2026.

• Quarterly Change in Account Payables rose 81.91% year-over-year to -$53000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $248000.0 (down 80.69% YoY) and the FY2025 annual result came in at $8000.0, down 99.4% from the prior year.
• Change in Account Payables declined to -$53000.0 in Q1 2026, from $15000.0 in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $1.2 million in Q4 2022 to a low of -$702000.0 in Q2 2023.
• A 5-year average of $61411.8 and a median of -$20000.0 in 2023 frame the typical range for Change in Account Payables.
• Annual changes were most pronounced in 2023 — Change in Account Payables slumped 394.96% — and 2024, when it surged 4795.0%.
• Tracing ACHV's Change in Account Payables over 5 years: stood at $1.2 million in 2022, then tumbled by 101.63% to -$20000.0 in 2023, then surged by 4795.0% to $939000.0 in 2024, then tumbled by 98.4% to $15000.0 in 2025, then plunged by 453.33% to -$53000.0 in 2026.
• The last three Change in Account Payables figures came in at -$53000.0 (Q1 2026), $15000.0 (Q4 2025), and $725000.0 (Q3 2025), per Business Quant data.